Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen F Madden

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Cancer Medicine|February 17, 2015
Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cellsKarolina Weiner-Gorzel, Eugene Dempsey, Malgorzata Milewska, et al.
Plos One|March 15, 2023
Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancerSandra Roche, Patricia Gaule, Deirdre Winrow, et al.
British Journal of Cancer|May 2, 2022
BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitorsMattia Cremona, Cassandra J Vandenberg, Angela M Farrelly, et al.
Lung Cancer (Amsterdam, Netherlands)|May 8, 2022
Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panelDaniel J Ryan, Sinead Toomey, Robert Smyth, et al.
NPJ Breast Cancer|June 26, 2021
The clinical and molecular significance associated with STING signaling in breast cancerEileen E Parkes, Matthew P Humphries, Elaine Gilmore, et al.
Cancer Discovery|November 1, 2011
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapyDavid G DeNardo, Donal J Brennan, Elton Rexhepaj, et al.
BMC Cancer|April 4, 2013
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancerPatrick C O Leary, Sarah A Penny, Roisin T Dolan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2020
Gene Expression Signatures of BRCAness and Tumor Inflammation Define Subgroups of Early-Stage Hormone Receptor-Positive Breast Cancer PatientsWerner Schroth, Florian A Büttner, Siarhei Kandabarau, et al.
British Journal of Cancer|July 28, 2023
Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapyNicola Gaynor, Alfonso Blanco, Stephen F Madden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2018
Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of CancerTamara Muliaditan, James W Opzoomer, Jonathan Caron, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Cancer Medicine|February 17, 2015
Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cellsKarolina Weiner-Gorzel, Eugene Dempsey, Malgorzata Milewska, et al.
Plos One|March 15, 2023
Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancerSandra Roche, Patricia Gaule, Deirdre Winrow, et al.
British Journal of Cancer|May 2, 2022
BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitorsMattia Cremona, Cassandra J Vandenberg, Angela M Farrelly, et al.
Lung Cancer (Amsterdam, Netherlands)|May 8, 2022
Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panelDaniel J Ryan, Sinead Toomey, Robert Smyth, et al.
NPJ Breast Cancer|June 26, 2021
The clinical and molecular significance associated with STING signaling in breast cancerEileen E Parkes, Matthew P Humphries, Elaine Gilmore, et al.
Cancer Discovery|November 1, 2011
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapyDavid G DeNardo, Donal J Brennan, Elton Rexhepaj, et al.
BMC Cancer|April 4, 2013
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancerPatrick C O Leary, Sarah A Penny, Roisin T Dolan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2020
Gene Expression Signatures of BRCAness and Tumor Inflammation Define Subgroups of Early-Stage Hormone Receptor-Positive Breast Cancer PatientsWerner Schroth, Florian A Büttner, Siarhei Kandabarau, et al.
British Journal of Cancer|July 28, 2023
Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapyNicola Gaynor, Alfonso Blanco, Stephen F Madden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2018
Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of CancerTamara Muliaditan, James W Opzoomer, Jonathan Caron, et al.
Pageof 8